Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 63951-64000 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06144164
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
PHASE3Recruiting
285 participants
Started: Nov 16, 2023 · Completed: Mar 16, 2030
6 conditions1 sponsor7 locations
NCT06205758
Efficacy and Safety Prediction of Milrinone or Levosimendan as Initial Inotropic Drug Therapy in Patients With Acute and Advanced Heart Failure With Renal Insufficiency
N/ARecruiting
1,600 participants
Started: Nov 16, 2023 · Completed: Jun 1, 2025
5 conditions2 sponsors1 location
NCT06557057
Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk
N/ARecruiting
75 participants
Started: Nov 16, 2023 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT06187805
Retrospective Case Series - OSSIX Volumax Collagen Xenograft Scaffolding
N/AEnrolling by invitation
15 participants
Started: Nov 16, 2023 · Completed: Feb 2, 2024
1 condition1 sponsor1 location
NCT06215222
Capsule Microbiota Sampling in IBS/Functional Gastrointestinal Disease
N/ARecruiting
40 participants
Started: Nov 16, 2023 · Completed: Dec 1, 2026
4 conditions1 sponsor1 location
NCT06120166
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Research
EARLY_PHASE1Recruiting
18 participants
Started: Nov 16, 2023 · Completed: Apr 5, 2026
1 condition2 sponsors1 location
NCT05743868
Metabolic Heterogeneity Underlying Hypertriglyceridemia: Hepatic Triglyceride Biosynthesis in Humans with Different Insulin Resistance Phenotypes
NARecruiting
40 participants
Started: Nov 16, 2023 · Completed: Dec 31, 2025
2 conditions3 sponsors1 location
NCT07091890
Effects of Topical Fluoride in Orthodontic Patients
NAActive, not recruiting
60 participants
Started: Nov 16, 2023 · Completed: Nov 30, 2025
4 conditions1 sponsor1 location
NCT06128343
Anatomical-Clinical Base of Adenocarcinoma Pancreatic
N/ARecruiting
1,500 participants
Started: Nov 16, 2023 · Completed: Feb 28, 2035
3 conditions1 sponsor8 locations
NCT05983276
Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer
PHASE2Recruiting
40 participants
Started: Nov 16, 2023 · Completed: Aug 28, 2031
1 condition2 sponsors1 location
NCT06016738
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
PHASE3Recruiting
510 participants
Started: Nov 16, 2023 · Completed: Sep 30, 2027
5 conditions1 sponsor193 locations
NCT06620055
Development of an Artificial Intelligence Model for Optimising Therapy in Gliomas Gliomas
N/ARecruiting
164 participants
Started: Nov 16, 2023 · Completed: Nov 16, 2028
1 condition1 sponsor3 locations
NCT06015659
ZN-c3 + Gemcitabine in Pancreatic Cancer
PHASE2Recruiting
34 participants
Started: Nov 16, 2023 · Completed: Jun 1, 2027
3 conditions4 sponsors1 location
NCT05761704
Exploratory Observation of Two Short-term Regimens After LAA Occlusion by LAMax LAAC® Device for Subjects With Non-valvular Atrial Fibrillation
NARecruiting
54 participants
Started: Nov 16, 2023 · Completed: May 16, 2025
1 condition1 sponsor1 location
NCT06126796
Urine-based Molecular Testing vs Cystoscopy for Surveillance of Nonmuscle Invasive Bladder Cancer (NMIBC)
N/AActive, not recruiting
107 participants
Started: Nov 16, 2023 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT05920356
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
PHASE3Recruiting
750 participants
Started: Nov 16, 2023 · Completed: Jun 30, 2031
1 condition1 sponsor373 locations
NCT06511557
Comparison of Effect of Virtual Reality and Kinetic Chain Exercises in Knee Osteoarthritis
NARecruiting
46 participants
Started: Nov 16, 2023 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT05931302
Initial Staging of Lobular Breast Carcinoma: Head to Head Comparison of 68Ga-FAPI-46 and 18F-FDG PET/CT
NAActive, not recruiting
40 participants
Started: Nov 16, 2023 · Completed: Nov 30, 2026
1 condition3 sponsors1 location
NCT06263322
The ROAMM-EHR Study
NARecruiting
50 participants
Started: Nov 16, 2023 · Completed: Oct 17, 2026
2 conditions2 sponsors1 location
NCT06091124
Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma
PHASE2Recruiting
22 participants
Started: Nov 16, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06091943
Study to Evaluate the Bioavailability of Tislelizumab Via Subcutaneous Injection in First-Line Treatment of Participants With Advanced or Metastatic Non-Small Cell Lung Cancer
PHASE1Active, not recruiting
62 participants
Started: Nov 16, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor15 locations
NCT05741112
The Long COVID-19 Wearable Device Study
NARecruiting
100,500 participants
Started: Nov 16, 2023 · Completed: Dec 1, 2025
6 conditions1 sponsor1 location
NCT04012645
Perfusion Outcomes With Near Infrared-Indocyanine Green Imaging System in Laparoscopic Total Mesorectal Excision for Mid- or Low-rectal CanceR
NARecruiting
547 participants
Started: Nov 16, 2023 · Completed: Dec 1, 2023
1 condition20 sponsors2 locations
NCT06170554
Study of Hydration Levels in Sports and Non-sports Schoolchildren (EHC)
N/AActive, not recruiting
259 participants
Started: Nov 16, 2023 · Completed: Oct 31, 2024
1 condition1 sponsor1 location
NCT05706922
Gut- and Vaginal Microbiome Composition in Association With PCOS
N/ARecruiting
200 participants
Started: Nov 16, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05608408
PRIME: PReservIng Memory in Epilepsy
NARecruiting
8 participants
Started: Nov 16, 2023 · Completed: Mar 31, 2028
1 condition2 sponsors2 locations
NCT06367244
Transplant Wellness Program
NARecruiting
420 participants
Started: Nov 16, 2023 · Completed: Nov 30, 2033
1 condition1 sponsor1 location
NCT06245772
CARegiver BURden, Effectiveness and Other Health Care Measures on Functional Disability, in Patients Treated With Abobotulinumtoxin A for Upper Limb Spasticity
N/ARecruiting
113 participants
Started: Nov 16, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor37 locations
NCT05975255
Dose Finding Study for Remimazolam in Children
PHASE2Recruiting
50 participants
Started: Nov 16, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06132451
In-Hospital Detection of Elevated Blood Pressure
NARecruiting
800 participants
Started: Nov 16, 2023 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT06498362
"The New Place of LEVETIRACETAM in the Management of Status Epilepticus in Children"
N/ARecruiting
151 participants
Started: Nov 16, 2023 · Completed: May 16, 2025
1 condition1 sponsor1 location
NCT05897879
Impact of Bacterial Expression and Immune Response in the Severity of Pertussis
NARecruiting
210 participants
Started: Nov 16, 2023 · Completed: Nov 16, 2026
1 condition15 sponsors14 locations
NCT06248775
Nursing Prehabilitation Intervention Supported With Technology for Vascular Surgery in People With Type 2 Diabetes
NARecruiting
24 participants
Started: Nov 16, 2023 · Completed: Jun 1, 2025
4 conditions1 sponsor1 location
NCT06173518
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
PHASE1Recruiting
30 participants
Started: Nov 16, 2023 · Completed: Nov 30, 2027
2 conditions1 sponsor8 locations
NCT06008054
A Study of SI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal Tumors
PHASE2Recruiting
376 participants
Started: Nov 16, 2023 · Completed: Dec 31, 2027
3 conditions2 sponsors1 location
NCT06153108
Monitoring Biomarker for Detecting Change in Physical Activity and Limb Function in Inclusion Body Myositis Over Time
N/AActive, not recruiting
20 participants
Started: Nov 16, 2023 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT06280300
Multi-disciplinary Care for Brain Metastases
NARecruiting
40 participants
Started: Nov 16, 2023 · Completed: Nov 1, 2025
1 condition1 sponsor1 location
NCT05758662
The Effect of Subclinical Leaflet Thrombosis and Prosthesis Type on Transcatheter Aortic Valve Degeneration (POPular PET TAVI)
N/ARecruiting
180 participants
Started: Nov 16, 2023 · Completed: Nov 30, 2025
1 condition3 sponsors4 locations
NCT06229522
Patients Derived Organoids as a Promising Tool to Tailor Ovarian Cancer Therapies (PANDORA).
N/ARecruiting
150 participants
Started: Nov 16, 2023 · Completed: Dec 31, 2037
1 condition1 sponsor1 location
NCT06162650
Total Neoadjuvant Therapy in Rectal Cancer
PHASE2Recruiting
42 participants
Started: Nov 16, 2023 · Completed: Nov 16, 2030
1 condition1 sponsor1 location
NCT07092644
Preeclampsia and Fetal Heart Malformations: Looking to Maternal Heart
NARecruiting
108 participants
Started: Nov 16, 2023 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT05911568
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
N/ARecruiting
1,060 participants
Started: Nov 16, 2023 · Completed: Apr 15, 2028
3 conditions4 sponsors18 locations
NCT05979051
A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis (EGPA)
PHASE2/PHASE3Recruiting
112 participants
Started: Nov 16, 2023 · Completed: May 16, 2027
1 condition1 sponsor2 locations
NCT06020014
Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult Patients With Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA
PHASE2Active, not recruiting
340 participants
Started: Nov 16, 2023 · Completed: Oct 30, 2025
1 condition1 sponsor124 locations
NCT06697886
A Study of the Efficacy and Safety of Antiwei Granules in the Treatment of Common Cold
PHASE3Recruiting
480 participants
Started: Nov 16, 2023 · Completed: Jul 1, 2025
1 condition1 sponsor24 locations
NCT06125106
Prospective, Single-arm, Multicenter Clinical Study on Haploidentical Hematopoietic Stem Cell Transplantation in Patients With MRD Positive CD19+ALL Treated With Conditioning Regimens Containing Blinatumomab
PHASE1Recruiting
31 participants
Started: Nov 16, 2023 · Completed: Feb 1, 2026
1 condition1 sponsor1 location
NCT06135246
Laser Therapy for Venous Leg Ulcers
NARecruiting
70 participants
Started: Nov 16, 2023 · Completed: Aug 1, 2024
3 conditions1 sponsor1 location
NCT06133062
Atezolizumab and Bevacizumab with Proton Radiotherapy for Unresectable Hepatocellular Carcinoma
PHASE2Recruiting
45 participants
Started: Nov 16, 2023 · Completed: Sep 30, 2030
1 condition1 sponsor1 location
NCT06113666
A Digital Therapeutic to Improve Insomnia in Multiple Sclerosis: A Randomized Controlled Trial.
NARecruiting
550 participants
Started: Nov 16, 2023 · Completed: Oct 30, 2029
2 conditions1 sponsor1 location
NCT05665608
Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation
NARecruiting
3,595 participants
Started: Nov 16, 2023 · Completed: Nov 30, 2027
2 conditions1 sponsor79 locations